Latest filing published 29 Oct 2026 for Maze Therapeutics, Inc., €427k.
Insider track record
No signal scores available.
Atul Dandekar: trading record in brief
Atul Dandekar is a declared insider of Maze Therapeutics, Inc., with filings sourced from SEC (Form 4). Between 29 July 2026 and 29 October 2026, the trades on record add up to 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 29 October 2026 with a transaction (€427k) in Maze Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Atul Dandekar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,000 shares@ US$31.73CommonSEC144:0001950047-26-010485
- 22,500 shares@ US$27.880.043% mcap100.0% of flowCommonSEC144:0001950047-26-007397
2 of 2 declarations
